Get started
Award

2024YFA1210100

Funded outputs count: 6
Funder award ID: 2024YFA1210100
OpenAlex ID: G3949880191
Synergistic nanosenolytic therapy reverses age-related dry eye disease by targeting cellular senescence and oxidative stress
2026 · Qianyi Ren, Xingyu Zhu, et al. · Bioactive Materials
Matrigel-Free Tumor Organoids on Microwell Arrays for CAR-T Cell Screening
2026 · Yang Yu, Yinchu Dong, et al. · Engineering
A hypoxia-responsive nanomedicine for cancer immunotherapy through ligand competition-induced dual-prodrug activation
2025 · Jiansen Li, Chen Cao, et al. · Journal of Colloid and Interface Science · 4
An engineered microbial nanohybrid for enhanced photothermal-chemodynamic therapy through controlled gas generation
2025 · Shujing Xu, Yuewei Li, et al. · Journal of Colloid and Interface Science · 5
Photo-activatable prodrug nanoparticles for reactive oxygen species amplification and cooperative cancer therapy
2025 · Xue Li, Xu Zhang, et al. · Colloids and Surfaces B Biointerfaces · 4
Histone deacetylase inhibiting nanoprodrugs for enhanced chemodynamic therapy through multistage downregulating glutathione
2025 · Yongxin Liu, Xinlu Zhang, et al. · International Journal of Biological Macromolecules · 3
Year
Topic